GGrantIndex
← Leaderboards

Fletcher A White

Rlr Va Medical Center

Google Scholar ↗PubMed ↗ORCID ↗
$5,383,750
Attributed
$7,586,925
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $912.8K · FY2006–25
$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,586,925 · 6
VA$0 · 3

By mechanism

R01$7,586,925 · 6
I01$0 · 3

Top collaborators

Others in their field

Top investigators on “Neurons”

Research focus

NeuronsNociceptionPainReceptorBehavioralCellsChronicAcuteSignal TransductionChronic PainLeadAnimalsMediatingDoseCytokineMaintenanceMolecularProductionRegulationIn VivoPainful NeuropathyAnalgesicsBaseSpinal Ganglia

Grant awards (30)

Novel treatments of fracture repair and bone pain$551,117
R01 · FY2025 · AR · contact PI
Novel treatments of chronic pain due to repetitive mild traumatic brain injury$0
I01 · FY2025 · VA · contact PI
Novel treatments of chronic pain due to repetitive mild traumatic brain injury$0
I01 · FY2025 · VA · contact PI
Novel treatments of fracture repair and bone pain$608,358
R01 · FY2024 · AR · contact PI
Safety, tolerability, and dose limiting toxicity of lacosamide in patients with painful chronic pancreatitis$304,462
R01 · FY2024 · DK
Small Molecules to Promote Regeneration and Recovery Following Spinal Cord Injury$0
I01 · FY2024 · VA · contact PI
Safety, tolerability, and dose limiting toxicity of lacosamide in patients with painful chronic pancreatitis$317,215
R01 · FY2023 · DK
Novel treatments of chronic pain due to repetitive mild traumatic brain injury$0
I01 · FY2023 · VA · contact PI
The role of cell-specific TLR-4 signaling in oxaliplatin-induced peripheral neuropathy$432,476
R01 · FY2022 · NS · contact PI
Safety, tolerability, and dose limiting toxicity of lacosamide in patients with painful chronic pancreatitis$390,258
R01 · FY2022 · DK
The role of cell-specific TLR-4 signaling in oxaliplatin-induced peripheral neuropathy$432,476
R01 · FY2021 · NS · contact PI
The role of cell-specific TLR-4 signaling in oxaliplatin-induced peripheral neuropathy$432,476
R01 · FY2020 · NS · contact PI
The role of cell-specific TLR-4 signaling in oxaliplatin-induced peripheral neuropathy$448,169
R01 · FY2019 · NS · contact PI
The role of cell-specific TLR-4 signaling in oxaliplatin-induced peripheral neuropathy$481,849
R01 · FY2018 · NS · contact PI
Chemokine signaling in the transition from acute to chronic pain$0
I01 · FY2017 · VA · contact PI
Chemokine signaling in the transition from acute to chronic pain$0
I01 · FY2016 · VA · contact PI
Chemokine signaling in the transition from acute to chronic pain$0
I01 · FY2015 · VA · contact PI
Chemokine signaling in the transition from acute to chronic pain$0
I01 · FY2014 · VA · contact PI
The role of DAMPS in painful bladder syndrome$390,000
R01 · FY2013 · DK · contact PI
Chemokine-mediated Modulaton of Opioid-induced Pain$285,209
R01 · FY2012 · DA
Chemokine-mediated Modulaton of Opioid-induced Pain$285,209
R01 · FY2011 · DA
Chemokine-mediated Modulaton of Opioid-induced Pain$294,030
R01 · FY2010 · DA
Mechanisms of Neuropathic Pain in Demylenated Nerves$269,431
R01 · FY2010 · NS · contact PI
Chemokine-mediated Modulaton of Opioid-induced Pain$297,000
R01 · FY2009 · DA
Mechanisms of Neuropathic Pain in Demylenated Nerves$158,261
R01 · FY2009 · NS · contact PI
Mechanisms of Neuropathic Pain in Demylenated Nerves$101,287
R01 · FY2009 · NS · contact PI
Chemokine-mediated Modulaton of Opioid-induced Pain$297,000
R01 · FY2008 · DA · contact PI
Mechanisms of Neuropathic Pain in Demylenated Nerves$259,548
R01 · FY2008 · NS · contact PI
Mechanisms of Neuropathic Pain in Demylenated Nerves$259,548
R01 · FY2007 · NS · contact PI
Mechanisms of Neuropathic Pain in Demylenated Nerves$291,546
R01 · FY2006 · NS · contact PI